Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine

In 77 euthyroid subjects the mean ratio between serum triiodothyronine (S-T3) in nmol/l X 10(3) and serum thyroxine (S-T4) in nmol/l was 22.4 with a standard deviation of 4.3. The distribution of the ratio was close to Gaussian. It was not changed in subjects under estrogen effect. The ratio was inc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of endocrinological investigation 1986-10, Vol.9 (5), p.407-412
Hauptverfasser: ERFURTH, E. M, HEDNER, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 412
container_issue 5
container_start_page 407
container_title Journal of endocrinological investigation
container_volume 9
creator ERFURTH, E. M
HEDNER, P
description In 77 euthyroid subjects the mean ratio between serum triiodothyronine (S-T3) in nmol/l X 10(3) and serum thyroxine (S-T4) in nmol/l was 22.4 with a standard deviation of 4.3. The distribution of the ratio was close to Gaussian. It was not changed in subjects under estrogen effect. The ratio was increased in hypothyroid subjects suggesting a mechanism preserving S-T3 better than S-T4 in thyroid failure. This mechanism seemed independent of TSH as the increasing S-T3/S-T4 ratio in primary hypothyroidism was not correlated to serum TSH (S-TSH), and patients with hypothyroidism of pituitary origin, without any increase in S-TSH, had a significantly elevated S-T3/S-T4 ratio. In subjects taking thyroxine, S-T4 but not S-T3 increased with the dose of thyroxine, leading to decreasing S-T3/S-T4 ratios. This indicates a mechanism that keeps S-T3 within normal limits also when the S-T4 supply is high. This applied also to athyreotic subjects on thyroxine and to subjects on thyroxine plus carbimazole, suggesting that the mechanism is independent of thyroid tissue, uninfluenced by carbimazole, and probably operates via the peripheral metabolism of T4. Changes in the S-T3/S-T4 ratio can be achieved by several mechanisms, and the specificity of ratio changes is low. However, by investigating the ratio S-T3/S-T4 in selected clinical states we can depict the ability of the organism to protect its normal S-T3 level in situations with divergent S-T4 concentrations, even if details about the mechanisms cannot be explained.
doi_str_mv 10.1007/bf03346952
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77200482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14672750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-b2c9f0c9d519100f865bc022345b5d0b083288895ac4fcff8f429a3b236d86253</originalsourceid><addsrcrecordid>eNqFkc1LxDAQxYMouq5evAs5iAehOs1HkxxV_ALBi55LkiYYaRtNuuD-90a3evU0DO83j5k3CB3VcF4DiAvjgVLWKE620KIWBCpJZbONFkBVXTFQYg_t5_wGQAWVYhftUqFYLfkCjc-v6xRDh19jGuLo8OAmbWIf8oDDiKdZ7UJ2OjusM07O985OrsNmXXSHk55CxNHj7NJqwFMKIXbxZ3IMxXGKG5vP0hygHa_77A7nukQvtzfP1_fV49Pdw_XlY2UZyKkyxCoPVnW8VuVCLxtuLBBCGTe8AwOSEiml4toyb72XnhGlqSG06WRDOF2i043ve4ofK5endgjZur7Xo4ur3IoSEjBJ_gVr1ggiOBTwbAPaFHMuIbTvKQw6rdsa2u8vtFe3v18o8PHsujKD6_7QOfain8y6zlb3PunRhvyHlb2kUoR-AUbDj7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14672750</pqid></control><display><type>article</type><title>Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>ERFURTH, E. M ; HEDNER, P</creator><creatorcontrib>ERFURTH, E. M ; HEDNER, P</creatorcontrib><description>In 77 euthyroid subjects the mean ratio between serum triiodothyronine (S-T3) in nmol/l X 10(3) and serum thyroxine (S-T4) in nmol/l was 22.4 with a standard deviation of 4.3. The distribution of the ratio was close to Gaussian. It was not changed in subjects under estrogen effect. The ratio was increased in hypothyroid subjects suggesting a mechanism preserving S-T3 better than S-T4 in thyroid failure. This mechanism seemed independent of TSH as the increasing S-T3/S-T4 ratio in primary hypothyroidism was not correlated to serum TSH (S-TSH), and patients with hypothyroidism of pituitary origin, without any increase in S-TSH, had a significantly elevated S-T3/S-T4 ratio. In subjects taking thyroxine, S-T4 but not S-T3 increased with the dose of thyroxine, leading to decreasing S-T3/S-T4 ratios. This indicates a mechanism that keeps S-T3 within normal limits also when the S-T4 supply is high. This applied also to athyreotic subjects on thyroxine and to subjects on thyroxine plus carbimazole, suggesting that the mechanism is independent of thyroid tissue, uninfluenced by carbimazole, and probably operates via the peripheral metabolism of T4. Changes in the S-T3/S-T4 ratio can be achieved by several mechanisms, and the specificity of ratio changes is low. However, by investigating the ratio S-T3/S-T4 in selected clinical states we can depict the ability of the organism to protect its normal S-T3 level in situations with divergent S-T4 concentrations, even if details about the mechanisms cannot be explained.</description><identifier>ISSN: 0391-4097</identifier><identifier>EISSN: 1720-8386</identifier><identifier>DOI: 10.1007/bf03346952</identifier><identifier>PMID: 3794185</identifier><identifier>CODEN: JEIND7</identifier><language>eng</language><publisher>Milano: Kurtis</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Carbimazole - therapeutic use ; Endocrinopathies ; Estrogens - adverse effects ; Estrogens - physiology ; Humans ; Hyperthyroidism - blood ; Hypothyroidism - blood ; Medical sciences ; Middle Aged ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Thyroid. Thyroid axis (diseases) ; Thyroxine - blood ; Thyroxine - pharmacology ; Thyroxine - therapeutic use ; Triiodothyronine - blood</subject><ispartof>Journal of endocrinological investigation, 1986-10, Vol.9 (5), p.407-412</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-b2c9f0c9d519100f865bc022345b5d0b083288895ac4fcff8f429a3b236d86253</citedby><cites>FETCH-LOGICAL-c408t-b2c9f0c9d519100f865bc022345b5d0b083288895ac4fcff8f429a3b236d86253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8238992$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3794185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ERFURTH, E. M</creatorcontrib><creatorcontrib>HEDNER, P</creatorcontrib><title>Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine</title><title>Journal of endocrinological investigation</title><addtitle>J Endocrinol Invest</addtitle><description>In 77 euthyroid subjects the mean ratio between serum triiodothyronine (S-T3) in nmol/l X 10(3) and serum thyroxine (S-T4) in nmol/l was 22.4 with a standard deviation of 4.3. The distribution of the ratio was close to Gaussian. It was not changed in subjects under estrogen effect. The ratio was increased in hypothyroid subjects suggesting a mechanism preserving S-T3 better than S-T4 in thyroid failure. This mechanism seemed independent of TSH as the increasing S-T3/S-T4 ratio in primary hypothyroidism was not correlated to serum TSH (S-TSH), and patients with hypothyroidism of pituitary origin, without any increase in S-TSH, had a significantly elevated S-T3/S-T4 ratio. In subjects taking thyroxine, S-T4 but not S-T3 increased with the dose of thyroxine, leading to decreasing S-T3/S-T4 ratios. This indicates a mechanism that keeps S-T3 within normal limits also when the S-T4 supply is high. This applied also to athyreotic subjects on thyroxine and to subjects on thyroxine plus carbimazole, suggesting that the mechanism is independent of thyroid tissue, uninfluenced by carbimazole, and probably operates via the peripheral metabolism of T4. Changes in the S-T3/S-T4 ratio can be achieved by several mechanisms, and the specificity of ratio changes is low. However, by investigating the ratio S-T3/S-T4 in selected clinical states we can depict the ability of the organism to protect its normal S-T3 level in situations with divergent S-T4 concentrations, even if details about the mechanisms cannot be explained.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carbimazole - therapeutic use</subject><subject>Endocrinopathies</subject><subject>Estrogens - adverse effects</subject><subject>Estrogens - physiology</subject><subject>Humans</subject><subject>Hyperthyroidism - blood</subject><subject>Hypothyroidism - blood</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Thyroxine - blood</subject><subject>Thyroxine - pharmacology</subject><subject>Thyroxine - therapeutic use</subject><subject>Triiodothyronine - blood</subject><issn>0391-4097</issn><issn>1720-8386</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1LxDAQxYMouq5evAs5iAehOs1HkxxV_ALBi55LkiYYaRtNuuD-90a3evU0DO83j5k3CB3VcF4DiAvjgVLWKE620KIWBCpJZbONFkBVXTFQYg_t5_wGQAWVYhftUqFYLfkCjc-v6xRDh19jGuLo8OAmbWIf8oDDiKdZ7UJ2OjusM07O985OrsNmXXSHk55CxNHj7NJqwFMKIXbxZ3IMxXGKG5vP0hygHa_77A7nukQvtzfP1_fV49Pdw_XlY2UZyKkyxCoPVnW8VuVCLxtuLBBCGTe8AwOSEiml4toyb72XnhGlqSG06WRDOF2i043ve4ofK5endgjZur7Xo4ur3IoSEjBJ_gVr1ggiOBTwbAPaFHMuIbTvKQw6rdsa2u8vtFe3v18o8PHsujKD6_7QOfain8y6zlb3PunRhvyHlb2kUoR-AUbDj7A</recordid><startdate>19861001</startdate><enddate>19861001</enddate><creator>ERFURTH, E. M</creator><creator>HEDNER, P</creator><general>Kurtis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19861001</creationdate><title>Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine</title><author>ERFURTH, E. M ; HEDNER, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-b2c9f0c9d519100f865bc022345b5d0b083288895ac4fcff8f429a3b236d86253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carbimazole - therapeutic use</topic><topic>Endocrinopathies</topic><topic>Estrogens - adverse effects</topic><topic>Estrogens - physiology</topic><topic>Humans</topic><topic>Hyperthyroidism - blood</topic><topic>Hypothyroidism - blood</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Thyroxine - blood</topic><topic>Thyroxine - pharmacology</topic><topic>Thyroxine - therapeutic use</topic><topic>Triiodothyronine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ERFURTH, E. M</creatorcontrib><creatorcontrib>HEDNER, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of endocrinological investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ERFURTH, E. M</au><au>HEDNER, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine</atitle><jtitle>Journal of endocrinological investigation</jtitle><addtitle>J Endocrinol Invest</addtitle><date>1986-10-01</date><risdate>1986</risdate><volume>9</volume><issue>5</issue><spage>407</spage><epage>412</epage><pages>407-412</pages><issn>0391-4097</issn><eissn>1720-8386</eissn><coden>JEIND7</coden><abstract>In 77 euthyroid subjects the mean ratio between serum triiodothyronine (S-T3) in nmol/l X 10(3) and serum thyroxine (S-T4) in nmol/l was 22.4 with a standard deviation of 4.3. The distribution of the ratio was close to Gaussian. It was not changed in subjects under estrogen effect. The ratio was increased in hypothyroid subjects suggesting a mechanism preserving S-T3 better than S-T4 in thyroid failure. This mechanism seemed independent of TSH as the increasing S-T3/S-T4 ratio in primary hypothyroidism was not correlated to serum TSH (S-TSH), and patients with hypothyroidism of pituitary origin, without any increase in S-TSH, had a significantly elevated S-T3/S-T4 ratio. In subjects taking thyroxine, S-T4 but not S-T3 increased with the dose of thyroxine, leading to decreasing S-T3/S-T4 ratios. This indicates a mechanism that keeps S-T3 within normal limits also when the S-T4 supply is high. This applied also to athyreotic subjects on thyroxine and to subjects on thyroxine plus carbimazole, suggesting that the mechanism is independent of thyroid tissue, uninfluenced by carbimazole, and probably operates via the peripheral metabolism of T4. Changes in the S-T3/S-T4 ratio can be achieved by several mechanisms, and the specificity of ratio changes is low. However, by investigating the ratio S-T3/S-T4 in selected clinical states we can depict the ability of the organism to protect its normal S-T3 level in situations with divergent S-T4 concentrations, even if details about the mechanisms cannot be explained.</abstract><cop>Milano</cop><pub>Kurtis</pub><pmid>3794185</pmid><doi>10.1007/bf03346952</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0391-4097
ispartof Journal of endocrinological investigation, 1986-10, Vol.9 (5), p.407-412
issn 0391-4097
1720-8386
language eng
recordid cdi_proquest_miscellaneous_77200482
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Adult
Aged
Biological and medical sciences
Carbimazole - therapeutic use
Endocrinopathies
Estrogens - adverse effects
Estrogens - physiology
Humans
Hyperthyroidism - blood
Hypothyroidism - blood
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Thyroid. Thyroid axis (diseases)
Thyroxine - blood
Thyroxine - pharmacology
Thyroxine - therapeutic use
Triiodothyronine - blood
title Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A30%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20hormone%20metabolism%20in%20thyroid%20disease%20as%20reflected%20by%20the%20ratio%20of%20serum%20triiodothyronine%20to%20thyroxine&rft.jtitle=Journal%20of%20endocrinological%20investigation&rft.au=ERFURTH,%20E.%20M&rft.date=1986-10-01&rft.volume=9&rft.issue=5&rft.spage=407&rft.epage=412&rft.pages=407-412&rft.issn=0391-4097&rft.eissn=1720-8386&rft.coden=JEIND7&rft_id=info:doi/10.1007/bf03346952&rft_dat=%3Cproquest_cross%3E14672750%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14672750&rft_id=info:pmid/3794185&rfr_iscdi=true